WASHINGTON, D.C., February 18, 2021 – As the COVID-19 vaccine is being administered across the country, the American Psychiatric Association called on state public health authorities today to include people with serious mental illness (SMI) and substance use disorders (SUD) to the equivalent of Centers for Disease Control and Prevention’s (CDC) Phase 1-C of their prioritization schedules. The recommendation coincides with APA’s recently released guidance document, The Role of the Psychiatrist in the Equitable Distribution of the COVID-19 Vaccine.
Phase 1-C, as defined by the CDC includes people who are 65-74 years old, essential workers, and anyone between ages 16-64 with high-...
Read More